NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹5.86 Cr | ₹1.72 Cr | ₹13 Cr | ₹0.83 Cr | ₹4.78 Cr |
What is the latest Cash and Bank ratio of NGL FINECHEM ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹5.86 Cr |
| Mar2024 | ₹1.72 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹0.83 Cr |
| Mar2021 | ₹4.78 Cr |
How is Cash and Bank of NGL FINECHEM Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.86 Cr | 240.93 | |
| Mar2024 | ₹1.72 Cr | -86.81 | |
| Mar2023 | ₹13 Cr | 1,475.00 | |
| Mar2022 | ₹0.83 Cr | -82.68 | |
| Mar2021 | ₹4.78 Cr | - | |
Compare Cash and Bank of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,390.0 Cr | 1.4% | -4.8% | 106.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1.4% |
-4.8% |
106.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses